Stefan H Hohnloser

Stefan H Hohnloser

Professor of Medicine and Cardiology

Johann Wolfgang Goethe University in Frankfurt, Germany

Biography

Stefan H Hohnloser is Professor of Medicine and Cardiology at the Johann Wolfgang Goethe University in Frankfurt, Germany, where he is the Head of the Department of Electrophysiology. His primary research interests include sudden cardiac death and its prevention by device therapy.

Read more

Media

PART 3: Practical implementation and current guidelines

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 22m 30s
PART 2: Evolution of the data

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 25m 57s
PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 16m 18s
DGK 2019: ELIMINATE-AF Studie - Prof Stefan H Hohnloser

Stefan H Hohnloser

Watch time: 3m 20s
DGK 2019: The ELIMINATE-AF Trial - Prof Stefan H Hohnloser

Stefan H Hohnloser

Watch time: 2m 58s
How do the data reported on concomitant use of ticagrelor

Stefan H Hohnloser

Watch time: 2m 4s
Which dabigatran dose would be recommended for patients with AF and ACS post-PCI?

Stefan H Hohnloser

Watch time: 1m 31s
What can we learn from the use of dual therapy with dabigatran in patients with different renal functions?

Stefan H Hohnloser

Watch time: 2m 25s
Image

Stefan H Hohnloser

Watch time: 2m 41s

Robert A Byrne, Prof Georg Nickenig, Stefan H Hohnloser, et al

Watch time: 30m 6s

Articles by Stefan H Hohnloser, Professor of Medicine and Cardiology

Optimal Anticoagulation Strategy for Cardioversion in Atrial Fibrillation

Philipp Bushoven, Sven Linzbach, Mate Vamos, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(1):44-6

DOI:

https://doi.org/10.15420/aer.2015.4.1.44
Atrial Fibrillation—Recent Key Trials on Anticoagulation

Stefan H Hohnloser,

Citation: US Cardiology 2007;4(1):18–9

DOI:

https://doi.org/10.15420/usc.2007.4.1.18